Our Infrastructure

Key partners for the neuro programme include:

The Leonard Wolfson Experimental Neurology Centre is a dedicated, specialist centre for the conduct of first-in-human studies of novel therapies for the treatment of neurodegenerative diseases.

The MRC Prion Unit was formed to provide a national centre of excellence with all necessary facilities to pursue a major long-term research strategy in prion and related diseases.

The MRC Centre for Neuromuscular Diseases is one of the MRC’s translational research centres and is a partnership between the UCL Institutes of Neurology and Child Health, and the University of Newcastle upon Tyne.

The Queen Square Multiple Sclerosis Centre unites all the research and care in MS at the Institute of Neurology in University College London (UCL), and the UCLH National Hospital for Neurology and Neurosurgery, Queen Square, in central London.

We have continued to increase the number of neurology patients into the bioresource with 4,440 recruited, 2,331 with MRI Imaging, 1,133 with genome-wide genotyping data and a further 2,308 with genotyping completed but still awaiting final return of results.

The OTRC is an initiative to bring together the 10 BRC centres for cross collaboration on research projects. The 4 main areas of focus will be: Radiotherapy, Nutrition, Surgery and Oncology. Focussing on exemplar projects to show how this collaboration between the BRC Centres can work, beginning with the HAMLET RT study which will be led by Oxford.